BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND IDH2, P48735, 3418, ENSG00000182054, IDHM, mNADP-IDH, IDH, IDP, ICD-M AND Diagnosis
40 results:

  • 1. [Mutation characteristics of angioimmunoblastic T-cell lymphoma: an analysis of 75 cases].
    Shen X; Yi HM; Li AQ; Ouyang BS; Dong L; Wang CF
    Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):29-33. PubMed ID: 38178743
    [No Abstract]    [Full Text] [Related]  

  • 2. Clinical and histological study of follicular helper T-cell lymphomas with indolent evolution.
    Messéant O; Drieux F; Sako N; Fataccioli V; Camus V; Robe C; Houot R; Tas P; Llamas-Gutierrez F; Lamaison C; Abraham J; Delage-Corre M; Benguerfi S; Bossard JB; Gaulard P; Lemonnier F
    Eur J Cancer; 2024 Jan; 197():113479. PubMed ID: 38128263
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Analysis of clinicopathological and molecular abnormalities of angioimmunoblastic T-cell lymphoma].
    Shi YF; Wang HJ; Liu WP; Mi L; Long MP; Liu YF; Lai YM; Zhou LX; Diao XT; Li XH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):521-529. PubMed ID: 37291929
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Gene Mutations and Targeted Therapies of Myeloid Sarcoma.
    Fu L; Zhang Z; Chen Z; Fu J; Hong P; Feng W
    Curr Treat Options Oncol; 2023 Apr; 24(4):338-352. PubMed ID: 36877373
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients.
    de Pádua Covas Lage LA; Barreto GC; Culler HF; Cavalcante JB; de Oliveira Alves LB; Nardinelli L; Bendit I; Zerbini MCN; Rocha V; Pereira J
    Cancer Biomark; 2022; 35(2):179-191. PubMed ID: 36093687
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Angioimmunoblastic T-Cell lymphoma with Exuberant CD30-Positive Follicular Dendritic Cell Proliferation in a SARS-CoV-2 Patient: The Role of Mutational Analysis to Exclude an Associated Follicular Dendritic Cell Sarcoma.
    Rogges E; Pelliccia S; Lopez G; Barresi S; Tafuri A; Alaggio R; Di Napoli A
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012614
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. What to use to treat AML: the role of emerging therapies.
    Thol F
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):16-23. PubMed ID: 34889359
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Nonmyeloablative Allogeneic Transplantation With Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia With idh Mutations: A Single Center Experience.
    Ambinder A; Smith M; Tsai HL; Varadhan R; DeZern A; Dalton W; Gocke C; Webster J; Gondek L; Gojo I; Ali SA; Huff CA; Swinnen L; Wagner-Johnston N; Showel M; Prince G; Borrello I; Bolaños-Meade J; Luznik L; Jain T; Imus P; Fuchs E; Ambinder R; Gladstone DE; Levis M; Jones R; Ghiaur G; Smith BD
    Clin Lymphoma Myeloma Leuk; 2022 Apr; 22(4):260-269. PubMed ID: 34750086
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Angioimmunoblastic T-cell lymphoma diagnosed from pleural fluid by integration of morphologic, immunophenotypic, and molecular findings.
    Tan B; Martin B; Fernandez-Pol S
    Diagn Cytopathol; 2021 Dec; 49(12):E462-E466. PubMed ID: 34449978
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Real-world assessment of isocitrate dehydrogenase inhibitor-associated differentiation syndrome.
    Megherea O; Janes C; Kowalski A; Baron J; Ahn E; Soule A; Newman M
    Leuk Lymphoma; 2021 Dec; 62(13):3219-3225. PubMed ID: 34313176
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Oncogenetic landscape and clinical impact of idh1 and idh2 mutations in T-ALL.
    Simonin M; Schmidt A; Bontoux C; Dourthe MÉ; Lengliné E; Andrieu GP; Lhermitte L; Graux C; Grardel N; Cayuela JM; Huguet F; Arnoux I; Ducassou S; Macintyre E; Gandemer V; Dombret H; Petit A; Ifrah N; Baruchel A; Boissel N; Asnafi V
    J Hematol Oncol; 2021 May; 14(1):74. PubMed ID: 33941203
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinicopathological characterization of follicular helper T-cell-derived peripheral T-cell lymphoma involving Waldeyer's ring.
    Wang J; Tang W; Zhang W; Wang J; Chen F; Zhong L; Chen Y; Chen G
    Virchows Arch; 2021 Aug; 479(2):355-363. PubMed ID: 33650043
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Germline ALK variations are associated with a poor prognosis in glioma and idh-wildtype glioblastoma.
    Bu L; Hameed NUF; Luo C; Hong P; Zhou X; Wang S; Wu S
    J Neurooncol; 2021 Mar; 152(1):27-36. PubMed ID: 33486679
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma.
    Zhang P; Zhang M
    Clin Epigenetics; 2020 Nov; 12(1):169. PubMed ID: 33160401
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Molecular epidemiology of idh2 hotspot mutations in cancer and immunohistochemical detection of R172K, R172G, and R172M variants.
    Dogan S; Frosina D; Geronimo JA; Hernandez E; Mohanty A; Bale T; Hechtman JF; Arcila ME; Hameed MR; Jungbluth AA
    Hum Pathol; 2020 Dec; 106():45-53. PubMed ID: 33017591
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Granular Cell Astrocytoma: A Diagnostic Conundrum.
    Dutta R; Sharma MC; Suri V; Sarkar C; Garg A; Srivastava A; Tandon V
    World Neurosurg; 2020 Nov; 143():209-213. PubMed ID: 32730969
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Peripheral T-cell lymphoma with follicular helper of T cell phenotype of Waldeyer's ring: a clinicopathological and genetic study of eight cases].
    Zhang DD; Li P; Hu PZ; Wang GN; Zhao WG; Zhang YP; Li WC
    Zhonghua Bing Li Xue Za Zhi; 2020 Jul; 49(7):686-692. PubMed ID: 32610379
    [No Abstract]    [Full Text] [Related]  

  • 18. Combination of multicolor flow cytometry for circulating lymphoma cells and tests for the
    Hayashida M; Maekawa F; Chagi Y; Iioka F; Kobashi Y; Watanabe M; Ohno H
    Leuk Lymphoma; 2020 Oct; 61(10):2389-2398. PubMed ID: 32476550
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Current concepts and future directions for hemato-oncologic diagnostics.
    Flach J; Shumilov E; Joncourt R; Porret N; Novak U; Pabst T; Bacher U
    Crit Rev Oncol Hematol; 2020 Jul; 151():102977. PubMed ID: 32446181
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Imaging and Radiologic-Pathologic Correlation in Granular Cell Astrocytomas: Report of 2 Cases.
    Montalvo Afonso A; Darriba Alles JV; Moreno Gutiérrez Á; González Quarante LH; García Leal R; Guzmán de Villoria Lebiedziejewski JA; Sola Vendrell E
    World Neurosurg; 2020 Feb; 134():164-169. PubMed ID: 31698124
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.